Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Suzana Jordan(University of Zurich), Thierry Zénone(Centre Hospitalier de Valence), Ulrich A. Walker(University Hospital of Basel), Francesca Ingegnoli(University of Milan), Rosario Foti(Université Paris Cité), Jörg Henes(University of Tübingen), Florenzo Iannone(University of Bari Aldo Moro), Alexandra Balbir‐Gurman(Technion – Israel Institute of Technology), Gabriela Riemekasten(Universitäres Kinderwunschzentrum Lübeck), Francesco Paolo Cantatore(University of Foggia), Øyvind Palm(Justus-Liebig-Universität Gießen), Jörg H. W. Distler(Düsseldorf University Hospital), Dörte Huscher(Zimmer Biomet (Germany)), Paola Caramaschi(University of Verona), Marco Matucci‐Cerinic(Vita-Salute San Raffaele University), Ilka Herrgott(Scripps Research Institute), L P Ananjeva(Hospital Universitario Doctor Peset), Jacob M. van Laar(University Medical Center Utrecht), Simona Rednic(Charité - Universitätsmedizin Berlin), Yannick Allanore(Inserm), Juan José Alegre Sancho(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Şule Yavuz(KU Leuven), Vanessa Smith(Lund University), Esthela Loyo(University of Milan), Oliver Distler(University Hospital of Zurich), R Westhovens(University of Basel), Veronica Codullo(Université de Strasbourg), Armando Gabrielli(Marche Polytechnic University), Carina Mihai(Carol Davila University of Medicine and Pharmacy), Codrina Ancuța(Academy of Medical Sciences), Britta Maurer(University of Zurich), Emmanuel Chatelus(Laboratoire National de Référence), Martin Aringer(University Hospital Carl Gustav Carus), A Scheja(Ospedali Riuniti Umberto I), Matija Tomšič(University of Debrecen), Gabriele Valentini(University of Campania "Luigi Vanvitelli"), Walid Ahmed Abdel Atty Mohamed, Marta Saracco, Dominique Farge(Hôpital Saint-Louis), Ulf Müller-Ladner, Edoardo Rosato(Sapienza University of Rome)
Cited by 432
Related Papers
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
|Annals of the Rheumatic Diseases|2019|1.5k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
|Nature Communications|2012|824